Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/LISATA-THERAPEUTICS-INC-30403115/news/Caladrius-Biosciences-gibt-Update-zur-Phase-2b-FREEDOM-Studie-mit-XOWNA-R-bei-koronarer-mikrovaskul-40528704/?utm_source=whatsapp&utm_medium=social&utm_campaign=share